| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-01-22 | State Street Global Advisors, Inc.法人 | -13.74M | 64.56k | Other Disposition | 13.77 - 16.87 | 49.32M | -21.79% |
| 2024-04-23 | State Street Global Advisors, Inc.法人 | -131.23M | 351.73M | Other Disposition | 10.38 - 19.50 | 41.55M | -75.95% |
| 2025-11-18 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | 233.76k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-18 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | -122.57k | 0.00 | Other Derivative Disposition | - | - | - |
| 2025-11-18 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | 34.17k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-20 | Dr. James Pacey NewcombeMD, CEO & Executive Director | 50.48k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-20 | Dr. James Pacey NewcombeMD, CEO & Executive Director | 345.34k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-18 | Dr. Colin Stephen Goldschmidtインサイダー | -321.64k | 0.00 | Other Derivative Disposition | - | - | - |
| 2025-10-16 | Ms. Nicola M. Wakefield EvansIndependent Non-Executive Director | 2.50k | 35.39k | 買い | 14.16 | 6.50k | 62.50% |
| 2025-10-03 | Dr. Katharine GilesIndependent Non-Executive Director | 1,000.00 | 14.35k | 買い | 14.35 | 4.60k | 27.78% |
| 2025-10-02 | Prof. Mark R. ComptonIndependent Non-Executive Chairman | 1.50k | 21.30k | 買い | 14.20 | 17.02k | 9.67% |
| 2025-10-01 | Prof. Christine Constance BennettIndependent Non-Executive Director | 1.10k | 15.62k | 買い | 14.20 | 8.20k | 15.49% |
| 2025-09-24 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | -111.59k | 0.00 | Other Derivative Disposition | 21.62 | - | - |
| 2025-09-24 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | -19.62k | 0.00 | Other Derivative Disposition | - | - | - |
| 2025-09-24 | Dr. Colin Stephen Goldschmidtインサイダー | -265.92k | 0.00 | Other Derivative Disposition | 21.62 | - | - |
| 2025-09-24 | Dr. Colin Stephen Goldschmidtインサイダー | -46.75k | 0.00 | Other Derivative Disposition | - | - | - |
| 2025-09-26 | Prof. Suzanne CroweNon-Executive Independent Director | 2.37k | 32.68k | 買い | 13.82 | 9.91k | 31.33% |
| 2025-09-26 | Ms. Kathryn Dianne SpargoNon-Executive Independent Director | 3.50k | 48.70k | 買い | 13.91 | 31.00k | 12.73% |
| 2025-09-02 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 630.56k | 0.60% |
| 2025-09-02 | Dr. Colin Stephen Goldschmidtインサイダー | 9.85k | 0.00 | Derivative Exercise and Retained Stock | - | 1.00M | 0.99% |
| 2022-09-27 | The Vanguard Group, Inc.法人 | 7.60M | 180.82M | 買い | 15.65 - 23.86 | 28.86M | 35.72% |
| 2022-09-30 | The Vanguard Group, Inc.法人 | -2.78M | 65.52M | 売り | 15.69 - 23.71 | 28.86M | -8.78% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。